financeneutral
UHS Stock: A Mixed Picture for Investors
Pennsylvania, USAMonday, May 25, 2026
Company Overview
- Location: Pennsylvania
- Business Scope: Hospitals & behavioral care centers nationwide
- Market Value: ~$9.6 billion
- Services: General surgery, pediatric care, and more
Stock Performance
| Metric | UHS | S&P 500 | Healthcare ETF |
|---|---|---|---|
| Last 12 mo | -15.5% | +28% | +18.6% |
| YTD | -27.6% | +9% | — |
UHS’s decline outpaces the broader market and a healthcare-focused ETF, widening the performance gap by over 40 points.
Q1 Earnings (Apr 27)
- Adjusted EPS: $5.62 vs. analysts’ $5.29
- Revenue: $4.50 billion vs. forecast $4.40 billion
FY Outlook: Analysts project a 7.4% EPS rise to $23.34 diluted, with mixed quarterly results (3/4 beats consensus).
Analyst Consensus
- Coverage: 19 analysts
- Ratings:
- Moderate Buy: 1 (previously 0)
- Strong Buy: 7
- Hold: 11
- Moderate Sell: 1
The consensus remains mildly bullish, a slight shift from last month.
Price Targets & Upside
| Analyst | Target | Upside vs. Current |
|---|---|---|
| JPMorgan (Benjamin Rossi) | $205 | ~30% |
| Average | $226 | 43% |
| Highest | $310 | ~97% |
Investors should weigh UHS’s earnings resilience against its lagging share price and assess long‑term growth versus current valuation.
Takeaway
UHS delivers solid earnings surprises but its stock lags the market. Potential upside exists, yet investors must consider whether long‑term growth prospects justify the present price.
Actions
flag content
